Healthcare Triangle, Inc. — Form S-1
Filed July 10, 2026 · analyzed by the Registration Agent
S-1
▼ Likely negative
significance 78/100
What the filing says
Healthcare Triangle (market cap ~$40.7M) registered 28M shares for resale by Hudson Global Ventures, LLC under an Equity Line of Credit (ELOC) Purchase Agreement dated June 12, 2026. The ELOC permits the company to direct Hudson to purchase up to $50M of common stock over 36 months at 94% of market prices, with Hudson receiving a warrant to purchase 50k shares at $0.00001/share. Company received $3.6M gross proceeds from concurrent convertible notes and completed a $50M acquisition of Spanish companies Teyame and Datono (closed Jan 29, 2026; cash + equity consideration including preferred stock convertible into 7.7M shares, subject to shareholder approval).
Why this rating
Massive dilution risk: 28M registered shares against 2M outstanding = 93%+ eventual dilution. ELOC at 4.99% beneficial ownership cap, but $50M potential raise is 122% of company market cap—existential for equity value. Teyame acquisition ($50M deal) adds execution risk.
Extracted items
- 2.02 results / earnings
- 7.01 Reg FD disclosure
See more from July 10, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.